Well-designed Cytisine - Ginkgo biloba extract – Chenlv Detail:
Active ingredient: ginkgo flavonoids
CAS No.: 90045- 36-6
Latin name: Ginkgo biloba L
Part used: leaves
Appearance: light yellow brown powder
Detection method: HPLC/UV
Specification:
ginkgo biloba total flavonoids – 24.0%
USP standard
CP Standard
EP Standard
Efficacy:
Ginkgo biloba extract is a commonly used traditional Chinese medicine for the treatment of cardiovascular and cerebrovascular diseases. it can increase cerebral vascular blood flow, improve cerebral vascular blood circulation function, protect brain cells, expand coronary artery, prevent angina pectoris and myocardial infarction, prevent thrombosis and improve immune ability of the body. It is very beneficial to coronary heart disease, angina pectoris, cerebral arteriosclerosis, Alzheimer’s disease and hypertension.
Product packaging: 25KG/drum
Validity period: 24 months
Product detail pictures:
Related Product Guide:
We have been convinced that with joint attempts, the business enterprise between us will bring us mutual benefits. We could guarantee you product or service good quality and aggressive value for Well-designed Cytisine - Ginkgo biloba extract – Chenlv, The product will supply to all over the world, such as: Ecuador , belarus , Cyprus , We insist on "Quality First, Reputation First and Customer First". We are committed to providing high-quality products and good after-sales services. Up to now, our products have been exported to more than 60 countries and areas around the world, such as America, Australia and Europe. We enjoy a high reputation at home and abroad. Always persisting in the principle of "Credit, Customer and Quality", we expect cooperation with people in all walks of life for mutual benefits.
By Rosemary from Portland - 2018.10.31 10:02
Company director has very rich management experience and strict attitude, sales staff are warm and cheerful, technical staff are professional and responsible,so we have no worry about product,a nice manufacturer.
By Kim from Rwanda - 2018.11.22 12:28